Company Filing History:
Years Active: 2016-2021
Title: Nadja Gruening: Innovator in Pharmaceutical Dosage Forms
Introduction
Nadja Gruening is a prominent inventor based in Aachen, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 2 patents, her work is recognized for its potential impact on medication administration.
Latest Patents
Nadja's latest patents focus on pharmaceutical dosage forms comprising 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine. These formulations are designed for administration twice daily, once daily, or less frequently, and include a physiologically acceptable salt of the compound. Her innovative approach aims to enhance the effectiveness and convenience of pharmaceutical treatments.
Career Highlights
Throughout her career, Nadja has worked with notable companies, including Grünenthal GmbH. Her experience in the pharmaceutical industry has equipped her with the knowledge and skills necessary to drive innovation in drug delivery systems.
Collaborations
Nadja has collaborated with professionals such as Marc Schiller and Ashish Hemani, contributing to a dynamic exchange of ideas and expertise in her field.
Conclusion
Nadja Gruening's contributions to pharmaceutical dosage forms exemplify her commitment to innovation in healthcare. Her patents reflect a dedication to improving patient outcomes through advanced medication delivery methods.